Consolidated Statements of Cash Flows - Unaudited - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Operating activities:
Net income attributable to Bryn Mawr Bank Corporation	$ 29,974	$ 18,477
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for loan and lease losses	4,167	208
Depreciation of fixed assets	3,033	2,792
Net amortization of investment premiums and discounts	1,509	1,352
Net gain on sale of investment securities available for sale	(7)	(1)
Net gain on sale of loans	(1,046)	(1,149)
Stock based compensation	1,235	915
Amortization and net impairment of mortgage servicing rights	366	387
Net accretion of fair value adjustments	(5,316)	(1,264)
Amortization of intangible assets	1,768	1,380
Impairment of OREO and other repossessed assets	0	200
Net (gain) loss on sale of OREO	(287)	12
Net increase in cash surrender value of bank owned life insurance (BOLI)	(576)	(401)
Other, net	(7,131)	(1,809)
Loans originated for resale	(44,108)	(57,248)
Proceeds from loans sold	44,663	58,940
Provision for deferred income taxes	640	614
Change in income taxes payable/receivable, net	6,277	(3,580)
Change in accrued interest receivable	1,131	(184)
Change in accrued interest payable	1,703	96
Net cash provided by operating activities	37,995	19,737
Investing activities:
Purchases of investment securities available for sale	(94,824)	(115,841)
Purchases of investment securities held to maturity	0	(2,335)
Proceeds from maturity and paydowns of investment securities available for sale	239,318	234,043
Proceeds from maturity and paydowns of investment securities held to maturity	77	42
Proceeds from sale of investment securities available for sale	7	130
Net change in FHLB stock	3,405	2,137
Proceeds from calls of investment securities	310	4,864
Net change in other investments	(4,304)	(55)
Purchase of domain name	0	(152)
Net portfolio loan and lease originations	(104,700)	(131,702)
Purchases of premises and equipment	(2,843)	(3,731)
Acquisitions, net of cash acquired	(380)	(4,792)
Capitalize costs to OREO	(15)	0
Proceeds from sale of OREO	420	68
Net cash provided by (used in) investing activities	36,471	(17,324)
Financing activities:
Change in deposits	(14,164)	102,125
Change in short-term borrowings	(10,806)	(73,856)
Dividends paid	(8,994)	(7,127)
Change in long-term FHLB advances and other borrowings	(51,372)	(25,000)
Payment of contingent consideration for business combinations	(631)	0
Cash payments to taxing authorities on employees' behalf from shares withheld from stock-based compensation	(732)	(98)
Net proceeds from sale of treasury stock for deferred compensation plans	99
Purchase of treasury stock for deferred compensation plans		(69)
Repurchase of warrants from U.S. Treasury	(1,755)	0
Proceeds from exercise of stock options	1,107	1,005
Net cash used in financing activities	(87,248)	(3,020)
Change in cash and cash equivalents	(12,782)	(607)
Cash and cash equivalents at beginning of period	60,024	50,765
Cash and cash equivalents at end of period	47,242	50,158
Supplemental cash flow information:
Income taxes	1,606	12,481
Interest	11,830	6,099
Non-cash information:
Change in other comprehensive loss	(6,777)	845
Change in deferred tax due to change in comprehensive income	(1,801)	455
Transfer of loans to OREO and repossessed assets	345	309
Acquisition of noncash assets and liabilities:
Assets acquired	1,466	7,284
Liabilities assumed	$ 687	$ 2,492